TREAT-NMD launches their Therapeutics Advisory Committee: T-TACThe TREAT-NMD Therapeutics Advisory Committee (T-TAC) consultation process is now completed and we are delighted with the breadth and calibre of international experts we have available as part of the T-TAC. We would therefore like to introduce them to the neuromuscular community via the launch of the TREAT-NMD Therapeutics Advisory Committee webpage on the TREAT-NMD website.
Cristina Csimma, the T-TAC chair, will lead this exciting initiative with the support of the nominated committee members and TREAT-NMD secretariat. The overall aim of the T-TAC is to provide guidance and advice to the neuromuscular community on the prioritisation of non-proprietary drugs as likely candidates for therapies for neuromuscular diseases.  MORE > |
TREAT-NMD Conference 2009We have finalised both sessions and speakers for the conference in Brussels and these details are now available on the conference website. Particular attention has been taken to create what we hope to be a diverse and lively conference.
Keynote speakers include Kenneth Fischbeck (NIH/NINDS) and Gert-Jan van Ommen (Leiden University). Each session has international representation from specialist areas.
We are very keen for this to be an inclusive conference with delegates and speakers interacting throughout. To begin this process we have a page on the conference website which allows delegates to post questions to speakers prior to the conference for their consideration.  MORE > |
German Muscular Dystrophy Network MD-NET - Annual MeetingThe German Muscular Dystrophy Network MD-NET has been funded by the German Federal Ministry of Education and Research as one of the national networks for rare diseases since 2003. In MD-NET, scientists and clinicians are collaborating in scientific projects on the pathomechanism of muscular dystrophies, as well as in optimizing diagnosis and treatment of patients. Adjacent to the first funding period of three years and an extension period, an additional funding period of three years (1.674.516 € for the period of 2009-2011) has recently been granted.  MORE > |
3rd TREAT-NMD Workpackage 8.2 Exon Skipping Meeting is a Success!The third workpackage 8.2 meeting on exon skipping was organized by Francesco Muntoni, Emma Heslop and Annemieke Aartsma-Rus and took place in Cagliari (Italy) on May 8. The focus of this meeting was on splicing and muscle perfusion. As usual unpublished data was presented by the participants to compare notes and coordinate future experiments under a confidentiality agreement.
 MORE > |
Introductory Newsletter for Central and Eastern EuropeTREAT‐NMD aims to be an inclusive rather than an exclusive network, and you do not have to be based in Europe or be a partner to be involved. International collaboration with experts from all over the world is already taking place, and new links are constantly being developed.
Maryze Schoneveld van der Linde has written and circulated an introductory newsletter for those living in Central and Eastern Europe(CEE) as part of her new role as European Neuromuscular Centre (ENMC) project manager for TREAT‐NMD.
 MORE > |
6th Annual SMA Research ConferenceJointly funded by the Jennifer Trust for SMA and the SMA Trust the 6th Annual Research Conference will take place in Edinburgh in early October.
Held in the Symposium Hall of the Royal College of Surgeons speakers include...
Dr Margarida Gama Carvalho - University of Lisbon
Professor Eugenio Mercuri -Universita Cattolica del Sacro Cuore
A call for abstracts has been made and the deadline for these is Friday 28th August 2009.
Registration for the conference itself closes on Friday 31st July 2009.  MORE > |
Job Opportunity - Managing Editor, Cochrane Neuromuscular Disease Group.National Hospital for Neurology and Neurosurgery. Maternity Cover for up to 14 months.
The Cochrane Neuromuscular Disease Group is part of the Cochrane Collaboration - an international organisation that publishes and maintains systematic reviews of the effects of healthcare interventions on The Cochrane Library.
The group is looking to appoint a Managing Editor to cover a period of maternity leave. The postholder will be based at the National Hospital for Neurology and Neurosurgery, MRC Centre for Neuromuscular Disease which houses the editorial base of the Group.  MORE > |
TREAT-NMD fellowships for WMS teaching courseAs part of the 14th International Congress of the World Muscle Society, a satellite teaching course will be held on the 8th and 9th September 2009. Aimed at medical specialists and those in training this course hopes to improve the diagnostic competence of professionals dealing with patients who have Neuromuscular Diseases.
There are five TREAT-NMD scholarships, covering fee and hotel costs up to a maximum of € 500,- in total, and is especially meant for young physicians specialising in neuromuscular diseases who are already involved in clinical trial work, coming from the former Eastern part of Europe, including accession countries, Western Balkan and Turkey.
Candidates should send their application for the course to Dr. Pierre-Yves Jeannet at Pierre-yves.Jeannet@chuv.ch and to apply for the TREAT-NMD scholarship to Katelijne Senden at senden@enmc.org. The application for the scholarship needs to be received by Katelijne Senden before June 30, 2009.  MORE > |